More SEC Filings
View Older Stories View Newer Stories-
Form D SUM Golden Eagle a serie
-
Form 8-K Star Holdings For: Feb 17
-
Form 4 TIMKEN CO For: Feb 12 Filed by: Discenza Michael Anthony
-
Form 4 MICROCHIP TECHNOLOGY For: Feb 12 Filed by: Bunker Mathew B
-
Form 10-K Orion S.A. For: Dec 31
-
Form 10-Q Adapti, Inc. For: Dec 31
-
Form 13F-HR Bayesian Capital Managem For: Dec 31
-
Form 4 NEXTERA ENERGY INC For: Feb 12 Filed by: Gough William John
-
Form 144 OmniAb, Inc. Filed by: GUSTAFSON KURT A
-
Form SCHEDULE 13G/A Vistagen Therapeutics, Filed by: Commodore Capital LP
-
Form 4 Klaviyo, Inc. For: Feb 12 Filed by: Ceran Jennifer
-
Form 4 PENTAIR plc For: Feb 13 Filed by: Rolchigo Philip M.
-
Form SCHEDULE 13G/A F5, INC. Filed by: HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC
-
Form 144 ROYAL CARIBBEAN CRUISES Filed by: BETHGE LAURA H
-
Form 4 Twist Bioscience Corp For: Feb 12 Filed by: Finn Patrick John
-
Form 13F-HR OCCUDO QUANTITATIVE STRA For: Dec 31
-
Form 144 WESCO INTERNATIONAL INC Filed by: Lazzaris Diane
-
Form 13F-HR Jericho Capital Asset For: Dec 31
-
Form 13F-HR Squadron Capital Managem For: Dec 31
-
Form 144 Neumora Therapeutics, Filed by: Pinto Joshua
-
Form SCHEDULE 13G Alkermes plc. Filed by: BAKER BROS. ADVISORS LP
-
Form SCHEDULE 13G GREEN DOT CORP Filed by: No Street GP LP
-
Form SCHEDULE 13G/A Dianthus Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form 144 IDEXX LABORATORIES INC Filed by: Vandebroek Sophie V.
-
Form D/A Apollo Aligned Alternati
-
Form SCHEDULE 13G/A EyePoint, Inc. Filed by: TCG Crossover GP II, LLC
-
Form SCHEDULE 13G/A Aptevo Therapeutics Inc. Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G EQUIFAX INC Filed by: HARRIS ASSOCIATES L P
-
Form 144 IDEXX LABORATORIES INC Filed by: Vandebroek Sophie V.
-
Form D/A Apollo Aligned Alternati
-
Form SCHEDULE 13G/A Septerna, Inc. Filed by: BIOTECHNOLOGY VALUE FUND L P
-
Form 13F-HR Merewether Investment For: Dec 31
-
Form 13F-HR Ancient Art, L.P. For: Dec 31
-
Form 8-K FIRSTENERGY CORP For: Feb 17
-
Form 424B2 CITIGROUP INC
-
Form 424B2 TORONTO DOMINION BANK
-
Form SCHEDULE 13G/A OLIN Corp Filed by: HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC
-
Form 13F-HR MASTERS CAPITAL MANAGEME For: Dec 31
-
Form 13F-NT Cite Gestion SA For: Dec 31
-
Form 144 GENTEX CORP Filed by: Nash Kevin C
-
Form 13F-HR Fortress Investment Grou For: Dec 31
-
Form 4 CORVEL CORP For: Feb 12 Filed by: HAMERSLAG STEVEN J
-
Form 144 ON SEMICONDUCTOR CORP Filed by: KEETON SIMON
-
Form SCHEDULE 13G/A ProMIS Neurosciences Filed by: GREAT POINT PARTNERS LLC
-
Form 4 TIMKEN CO For: Feb 12 Filed by: Lanzarotta Megan Renee
-
Form 13F-HR Greycroft LP For: Dec 31
-
Form 13F-HR Signature Equity Partner For: Dec 31
-
Form 144 Neumora Therapeutics, Filed by: BERNS PAUL L
-
Form S-8 ROCKWELL AUTOMATION,
-
Form SCHEDULE 13G/A AVADEL PHARMACEUTICALS Filed by: Two Seas Capital LP

